Document is current
Any future updates will be listed below
-
Authors
Tang, Lars Hermann https://orcid.org/0000-0001-6055-8696
Zangger, Graziella
Holm, Pætur Mikal
Hamborg, Trine Grønbek
Skou, Søren T.
Simonÿ, Charlotte
Mortensen, Sofie Rath
-
Funding
Funding for this research was provided by:
The Danish Regions' Collective Regional Fund for Prevention Research (R260-A6045)
Regional Zealand (Exercise First)
Næstved-Slagelse-Ringsted Hospitals research fond (A1277)
H2020 European Research Council (801790)
Region Zealand Health Sciences Research Fund (A1868)
Næstved-Slagelse-Ringsted Hospitals Research Fund (A1961)
Næstved-Slagelse-Ringsted Hospitals' Research Fund (A2125)
University of Southern Denmark
- License Information
-
More Information
Article History
Received: 2 April 2025
Accepted: 17 July 2025
First Online: 20 August 2025
Declarations
:
: The study was approved by the Danish Protection Agency (REG-095–2023). According to Danish law, this study could not be considered for ethical approval as it did not include human biological material (). The study adheres to the principles outlined in the Declaration of Helsink.
: Informed consent, was obtained from each participant as part of participation in the Regional National Health Survey.
: Not applicable.
: Dr. Skou is the co-founder of GLA:D®, which is a non-profit initiative hosted at the University of Southern Denmark aimed at implementing clinical guidelines for OA in clinical practice. Furthermore, he has received personal fees from Munksgaard, TrustMe-Ed, and Nestlé Health Science outside the submitted work. The rest of the authors report no other potential conflict of interest.
